Several open-label trials have demonstrated that administering metreleptin to correct overt hypoleptinemia significantly improves the metabolic abnormalities and insulin resistance in patients ...

Myalept (metreleptin) has been approved in the US to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy ...

SAN DIEGO — Results from a new analysis of an ongoing, long-term research study of the investigational drug metreleptin, an analog of the human hormone leptin, demonstrated robust reductions in ...

VANCOUVER, British Columbia & CAMBRIDGE, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new ...

SAN DIEGO — An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study. Amylin Pharmaceuticals announced Saturday results of a ...

VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new ...

HealthDay News — For patients with lipodystrophy (LD), resting-state connectivity is significantly increased in 3 brain areas with metreleptin treatment, with decreased hunger feelings and ...

- If approved, metreleptin would be the first medication available in the EU to treat generalized and partial lipodystrophies - More than 100 patients are currently treated with metreleptin via a ...

DUBLIN, Ireland, and Boston MA, January 20, 2021, Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel therapeutics to treat ...

NIH study showed metreleptin treatment reduced HbA1c, triglycerides, and liver function tests in children and adolescents with lipodystrophy during a 12-month period.

* Patients treated with Metreleptin experienced clinically meaningful reductions from baseline in HBA1C, liver enzymes (AST, ALT), triglycerides * For patients assessed within one year of ...

Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada DUBLIN, Ireland, and Boston MA, March 8, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial ...